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Abstract
The  feasibility  of  calcium  carbonate-based  cements  involving  the  re-crystallization  of 
metastable  calcium carbonate  varieties  has  been demonstrated.  Two cement  compositions 
were obtained by mixing either calcium carbonate phases (cement A) or a calcium carbonate 
and a calcium phosphate phase (cement B) with an aqueous media. These cements set and 
hardened after 30 minutes and 90 minutes respectively. The final composition of cement A 
was calcite and aragonite whereas cement B lead to a carbonated apatite analogous to bone 
mineral. Despite poor mechanical properties the presence of a high carbonate content in the 
final  phase  might  be  of  interest  to  increase  the  cement  resorption  rate  and  to  favour  its 
replacement by bone tissue. First assays of implantation performed on fresh anatomical pieces 
(fresh  cadavers)  at  37°C  revealed  important  advantages  of  such  cement  compositions: 
easiness of use, rapid setting, good adhesion to bone, very good homogeneity and stability of 
the cement.
Introduction
Calcium phosphate (CaP) bone cements have developed considerably in the last few years 
essentially  as  bone filling and bone reinforcement  biomaterials  [1-3].  However,  the main 
challenge  is  to  reach  higher  mechanical  properties,  higher  rates  of  resorption  and  an 
improvement of bone formation.
Aragonite,  a  natural  calcium  carbonate  (CaCO3)  from  corals,  has  been  shown  to  be  a 
biocompatible and bioactive bone substitute and is being used for more than 15 years [4]. 
Considering that the resorption rate of bone substitute materials is related to their solubility, 
calcium carbonates, which exhibit a higher solubility than calcium phosphates, should show 
an improved biodegradation rate compared to CaP cements [5]. In addition, like in the case of 
the widespread BCP ceramics (biphasic calcium phosphate ceramics) made of HA and TCP, 
calcium carbonates  could be used to  produce  biphasic  cements  with adaptable  resorption 
rates. 
This work is a preliminary study on new types of bone cements based on calcium carbonate 
and prepared by mixing either calcium carbonate phases or calcium carbonate and calcium 
phosphate phases with an aqueous media. 
Materials and Methods
Calcium carbonate phases (aragonite, vaterite and a metastable calcium carbonate mixture 
comprising  calcite,  vaterite  and  amorphous  CaCO3)  and  dicalcium  phosphate  dihydrate 
(DCPD: CaHPO4, 2H2O) were prepared by double decomposition in aqueous media. 
The  cement  powders  were  constituted  by  a  mixture  of  several  calcium carbonate  phases 
(cement A) or a mixture of calcium carbonate (at least 40 % w/w) and calcium phosphate 
(cement B) (see Table 1). The cement paste was obtained by mixing the powders with an 
appropriate amount of liquid phase (either deionized water or a sodium chloride solution: 
0.9% w/w). The wet paste was wrapped in wet paper and placed in a sealed container at 37°C 
for setting and hardening. 
The setting rate of the cement was followed with a TA–XT2 Texture Analyser fitted with a 
cylindrical  needle  (0.7  mm  in  diameter).  The  setting  time  was  reached  when  the  paste 
developed  a  resistance  force  to  needle  penetration  higher  than  600  g/mm2.  The  cement 
compressive strength was evaluated on a Hounsfield Series S apparatus.
The cements were characterized by transmission FTIR spectroscopy on KBr pellets (Perkin 
Elmer FTIR 1600 spectrometer) and by X-ray diffraction (Inel CPS 120 diffractometer) using 
a Co anticathod.
Implantation tests were performed at 37°C on fresh anatomical pieces (fresh cadavers) at the 
Laboratoire d'Anatomie Médico-Chirurgicale Appliquée of the University of Bordeaux where 
surgeons in dentistry have evaluated the preparation of the cement, either with physiological 
serum or blood as liquid phase, and its implantation for odontostomatology applications.
Results 
The composition of the initial solid phase and the range of the liquid on solid ratio (L/S) used 
for the two kinds of cement compositions are reported in Table 1. 
Table 1: Cement A and cement B compositions
Cement A Cement B
Solid phase: 
Aragonite + metastable CaCO3 
L/S = 0.25-0.50
Solid phase: 
Aragonite + vaterite + DCPD
L/S = 0.5-1.0
The FTIR absorption spectra of the final phase for the two cement compositions are presented 
in Fig. 1. After hardening cement A appeared essentially composed of calcite and aragonite 
whereas cement B lead to a carbonated apatite analogous to bone mineral. 
Figure 1: FTIR spectrum of the ending phase(s) of cement A and cement B
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Moreover,  a  detailed  study  of  various  phase  compositions  of  type  A  cement  by  FTIR 
spectroscopy and X-rays diffraction revealed that setting did not occur if vaterite, from the 
initial metastable CaCO3 powder, remained in the ending cement and/or if the proportion of 
aragonite  in  the  resulting  cement  was  lower  than  50  % (w/w)  (data  not  presented).  The 
carbonate content in the carbonated apatite of the type B cement depended on the proportion 
of calcium phosphate in the initial solid phase: the CO32- content was around 10 % (w/w) for a 
cement prepared with 57 % (w/w) of DCPD and L/S=1.
Scanning electron microscopy (see Fig.  2) showed that the resulting cements were 
microporous.  For,  cement  A,  cubic  or  rhomboedral  crystals  characteristic  of  calcite  were 
distinctly observed whereas cement B appeared mainly formed by a poorly crystalline phase.
a) b) 
Figure 2: SEM micrographs of the ending phase of a) cement A and b) cement B
Figure 3: Setting time evaluation for cement A (A1: L/S = 0.38; A2: L/S= 0.25)
and cement B (L/S = 0.71)
The setting kinetics of each cement is represented in Fig. 3. The setting of cement A and 
cement B occurred before 30 min and 90 min, respectively. As usually observed, a decrease 
of the proportion of liquid phase leads to a significant increase of  the mechanical strength. 
After the setting time and during the hardening phase,  a  high increase of the mechanical 
strength of cement B occurred. This observation was confirmed by measurement of cement 
compressive strength which was higher for cement B than for cement A but remained poor in 
all cases: around 3 MPa for cement A and around 7 MPa for cement B.
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Discussion and conclusion
FTIR and X-ray diffraction analyses revealed the presence of calcite and aragonite in the A-
type cement paste after hardening. The follow-up of the phase composition during the setting 
and  hardening  periods  evidenced  the  transformation  of  the  initial  metastable  calcium 
carbonate phases into aragonite or calcite (data not presented). A detailed analysis of the data 
suggested that the hardening process resulted essentially from the transformation of vaterite 
from the  metastable  CaCO3 phase  into  aragonite  [6].  For  cement  B,  the  setting  reaction 
appeared essentially related to the formation of a  carbonated apatite  phase by reaction of 
DCPD onto calcium carbonate.
Calcium carbonate materials from biological origin have been used and proposed as bone 
substitute materials. However, despite a good biological behaviour, question remains about 
the biological role of organic matter residues. Although several attempts have been made to 
produce synthetic calcium carbonate, sintering appears as a difficult technique and calcium 
carbonate  cements  seems  an  interesting  alternative  way.  These  cements,  unlike  sintered 
materials and natural materials could be associated with known biological active molecules. 
The formation of a poorly crystalline carbonated apatite analogous to bone mineral and the 
possibility to adapt the carbonate level in the resulting apatite is another interesting features of 
the type B biomimetic cement.
The proposed ionic cement formulae are biphasic (two calcium carbonate phases or calcium 
carbonate  and  calcium  phosphate  phases)  which  is  an  interesting  characteristic  enabling 
adaptation of  the cement  biodegradation properties depending on the surgical application. 
This  feature  can  be  compared  to  that  of  the  well-known  biphasic  biomedical  ceramics: 
HAP/TCP.
Even though the mechanical  properties measured remained poor,  they do not seem to be 
detrimental  to  in  vivo  application  in  locations  under  low  mechanical  stress  and  these 
properties can be improved by optimizing the L/S ratio. 
First assays of implantation performed on fresh anatomical pieces (fresh cadavers) revealed 
important advantages of such cement compositions: easiness of use, rapid setting at 37°C, 
perfect adhesion to bone, very good homogeneity and stability of the cement. Before in vivo 
implantation,  the  cement  compositions  have  to  be  evaluated  for  cytotoxicity  and 
cytocompatibility  in  vitro.  The  expected  rate  of  cement  biodegradation  and  bone 
reconstruction after in vivo implantation of cement A and B would be a decisive advantage 
for the development of such formulations especially to improve bone regeneration in dental 
surgery (post-extractional and bone defect filling, stabilization during dental implant fitting).
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